Company Performance: Progenics Therapeutics operational and financial performance directly influences its stock. Positive clinical trial results, successful drug approvals, and strong revenue growth typically lead to stock price increases.

Market Sentiment: Overall investor sentiment towards the biotechnology sector and pharmaceutical industry affects PROGEN.ST. Optimism about industry growth prospects can drive up stock prices, while pessimism can depress them.

Regulatory Events: Regulatory decisions by health agencies, such as FDA, regarding Progenics' drugs significantly impact stock value. Approvals boost prices, while rejections or delays can cause declines.

Competition: The competitive landscape within the pharmaceutical market influences investor perception. Introduction of competing drugs or therapies can negatively affect PROGEN.ST if they pose a threat to Progenics' market share.

Macroeconomic Factors: Broader economic conditions, including interest rates, inflation, and economic growth, impact stock prices. Economic downturns can reduce investor risk appetite, leading to sell-offs in more volatile stocks like PROGEN.ST.

News and Events: Company-specific news, such as management changes, partnerships, or acquisitions, can cause fluctuations in stock price. Positive news typically boosts prices, while negative news can depress them.

Analyst Ratings: Recommendations from financial analysts influence investor decisions. Positive ratings and price targets can encourage buying, while negative ratings can lead to selling pressure.

Clinical Trial Outcomes: The outcomes of clinical trials for Progenics' drug candidates are major price catalysts. Successful trial results that demonstrate efficacy and safety often lead to significant stock price appreciation.

Patent Protection: The strength and duration of patent protection for Progenics' products are crucial for maintaining market exclusivity and profitability. Loss of patent protection or challenges to patents can negatively affect stock value.

Investor Expectations: The market's expectations for Progenics' future performance play a significant role. If the company fails to meet expectations, even with positive results, the stock price may decline.